We are live on
!
Find out more
B
Bayban Portfolio holdings
AUM
$130M
This Fund
S&P 500
This Quarter
Est. Return
+2.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow
% of AUM
99.36%
Top 10 Holdings %
Top 10 Hldgs %
40.85%
Holding
613
New
613
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$13.8M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$6.06M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$5.15M |
| 4 |
Apple
AAPL
|
+$4.67M |
| 5 |
US Bancorp
USB
|
+$3.94M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.96% |
| 2 | Healthcare | 16.42% |
| 3 | Financials | 11.34% |
| 4 | Technology | 10.67% |
| 5 | Industrials | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
iShares S&P 500 Value ETF
IVE
$48.6B
| $21.2K | 0.02% |
+100
| New | +$21K |
2025 Q4
0 quarters
|
|
327
Vanguard Materials ETF
VAW
$2.85B
| $21.2K | 0.02% |
+102
| New | +$20.6K |
2025 Q4
0 quarters
|
|
328
Toro Company
TTC
$9.34B
| $21.1K | 0.02% |
+268
| New | +$19.8K |
2025 Q4
0 quarters
|
|
329
Vanguard Russell 1000 Growth ETF
VONG
$47.5B
| $21.1K | 0.02% |
+173
| New | +$21.1K |
2025 Q4
0 quarters
|
|
330
BP
BP
$115B
| $20.8K | 0.02% |
+600
| New | +$21K |
2025 Q4
0 quarters
|
|
331
KeyCorp
KEY
$21.4B
| $20.6K | 0.02% |
+1,000
| New | +$18.6K |
2025 Q4
0 quarters
|
|
332
Colgate-Palmolive
CL
$67.2B
| $20.5K | 0.02% |
+260
| New | +$20.4K |
2025 Q4
0 quarters
|
|
333
Zurn Elkay Water Solutions
ZWS
$7.91B
| $20K | 0.02% |
+431
| New | +$20.2K |
2025 Q4
0 quarters
|
|
334
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $19.9K | 0.02% |
+207
| New | +$19.9K |
2025 Q4
0 quarters
|
|
335
Dutch Bros
BROS
$5.33B
| $19.9K | 0.02% |
+325
| New | +$18.5K |
2025 Q4
0 quarters
|
|
336
Amkor Technology
AMKR
$13.9B
| $19.7K | 0.02% |
+500
| New | +$17.8K |
2025 Q4
0 quarters
|
|
337
GoDaddy
GDDY
$12.3B
| $19.5K | 0.02% |
+157
| New | +$20.3K |
2025 Q4
0 quarters
|
|
338
Lennox International
LII
$12.3B
| $19.4K | 0.02% |
+40
| New | +$20K |
2025 Q4
0 quarters
|
|
339
Morgan Stanley
MS
$299B
| $19.4K | 0.02% |
+109
| New | +$18.2K |
2025 Q4
0 quarters
|
|
340
Vanguard Intermediate-Term Treasury ETF
VGIT
$38.7B
| $18.9K | 0.02% |
+315
| New | +$18.9K |
2025 Q4
0 quarters
|
|
341
State Street SPDR Dow Jones REIT ETF
RWR
$1.76B
| $18.8K | 0.02% |
+191
| New | +$19K |
2025 Q4
0 quarters
|
|
342
Simon Property Group
SPG
$65B
| $18.5K | 0.02% |
+100
| New | +$18.2K |
2025 Q4
0 quarters
|
|
343
Intel
INTC
$631B
| $18.4K | 0.02% |
+500
| New | +$18.9K |
2025 Q4
0 quarters
|
|
344
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $18.3K | 0.02% |
+150
| New | +$17.2K |
2025 Q4
0 quarters
|
|
345
Hershey
HSY
$32.2B
| $18.2K | 0.02% |
+100
| New | +$18.3K |
2025 Q4
0 quarters
|
|
346
Unilever
UL
$129B
| $17.9K | 0.02% |
+274
| New | +$18.4K |
2025 Q4
0 quarters
|
|
347
Knife River
KNF
$2.86B
| $17.8K | 0.02% |
+253
| New | +$17.8K |
2025 Q4
0 quarters
|
|
348
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.08B
| $17.6K | 0.02% |
+220
| New | +$17.9K |
2025 Q4
0 quarters
|
|
349
Fidelity Quality Factor ETF
FQAL
$1.43B
| $17.5K | 0.02% |
+232
| New | +$17.4K |
2025 Q4
0 quarters
|
|
350
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$49.9B
| $17.4K | 0.02% |
+190
| New | +$17.4K |
2025 Q4
0 quarters
|
|
Similar funds
4A
BNA
SCC
HGP
WHC
RHDIC
LIP
PAWC
Bayban's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Bayban, which disclosed 613 positions worth $113M. Its ten largest holdings account for 41% of the portfolio.
Its largest position is UnitedHealth: 40,639 shares worth $13.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, followed by Healthcare and Financials.
- Bayban's largest Q4 2025 buy was UnitedHealth: 40,639 shares worth $13.4M.
- Bayban's ten largest holdings make up 41% of its $113M portfolio in Q4 2025.
- Bayban disclosed 613 positions in Q4 2025, its first 13F filing on record.
Based on Bayban's 13F filing for Q4 2025, filed 5 Mar 2026.